產品目錄 Home 主打產品 植物提取物 天然提取物 產品解決方案 聯繫我們 展會
藤茶提取物二氫楊梅素 Dihydromyricetin
楊梅素 Myricetin
木犀草素Luteolin
苦杏仁甙amygdalin
綠原酸Chlorogenic acid
芹菜素apigenin
厚朴提取物Magnolia bark extract
厚朴酚magnolol
和厚朴酚Honokiol
博落回提取物Macleaya cordata extract
血根碱sanguinarine
白屈菜紅碱Chelerythrine
迷迭香提取物rosemary leaf extract
迷迭香酸rosmarnic aicd
鼠尾草酸Carnosic acid
熊果酸Ursolic acid
鼠尾草酸油carnosic acid liquid oil
綠咖啡豆提取物green coffee bean extract
金銀花提取物honeysuckle flower extract
巴拿巴葉提取物Banaba leaf extract
枇杷葉提取物Loquat leaf extract
漆黃素Fisetin
虎杖甙Polydatin
芒果甙mangiferin
白樺脂醇Betulin
石杉碱甲huperzine a
阿魏酸Ferulic acid
白藜蘆醇Resveratrol

白藜蘆醇Resveratrol 

白藜蘆醇

品名:白藜蘆醇

來源:虎杖

CAS號:501-36-0

分子式:C14H12O3

檢測方式: HPLC

 

虎杖是蓼科的植物之一,其原生長于東亞並廣氾分布于中國。虎杖在中國和日本傳統醫藥中被用於治療多種病痛,其中包括黴菌感染,多種皮膚炎症,心血管疾病和肝臟疾病等。 白藜蘆醇大黃素是虎杖中的主要功能成分。研究顯示白藜蘆醇和大黃素表現出廣氾的抗氧化特性,如LDL膽固醇氧化和脂質過氧化反應。白藜蘆醇同時顯示出有助於心血管健康和活血,減輕疼痛,清熱去濕,去毒去痰。其它成分包括丹蒽酮大黃素甲醚大黃酸都具有抗炎症,祛關節炎和抗微生物活性。

 

上禾生物專業生產虎杖提取物白藜蘆醇,大黃素等。價格優惠,隨時發貨。產品詳詢:13657416805

  1. 參考文獻:
  2. 1.Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493–506
  3. 2.Bemis DL, Katz AE, Buttyan R (2006) Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert Opin Investig Drugs 15: 1191–200
  4. 3.Aggarwal BB, Bhardwaj A, Aggarwal RS et al. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783–2840
  5. 4.Joe AK, Liu H, Suzui M et al. (2002) Resveratrol induces growth inhibition, S phase arrest, apoptosis and changes biomarker expression in several human cancer cell lines. Clin Cancer Res 8: 893–903
  6. 5.Soleas GJ, Grass L, Josephy PD et al. (2006) A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 39: 492–497
  7. 6.Providencia R (2006) Cardiovascular protection from alcoholic drinks: scientific basis of the French Paradox. Rev Port Cardiol 25: 1043–1058
  8. 7.Ovesna Z, Kozics K, Bader Y et al. (2006) Antioxidant activity of resveratrol, piceatannol and 3,3’,4,4’,5,5’-hexahydroxy-trans-stilbene in three leukemia cell lines. Oncol Rep 16: 617–624
  9. 8.Athar M, Back JH, Tang X et al. (2007) Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol (in press)
  10. 9.Ovesna Z, Horvathova-Kozics K (2005) Structure-activity relationship of trans-resveratrol and its analogues. Neoplasma 52: 450–455
  11. 10.Pezutto JM (2004) Resveratrol: a whiff that induces a biologically specific tsunami. Cancer Biol Ther 3: 889–890
  12. 11.Aziz MH, Nihal M, Fu VX et al. (2006) Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3’-kinase/Akt pathway and Bcl-family proteins. Mol Cancer Ther 5: 1335–1341
  13. 12.Liao Z, Mason KA, Milas L (2007) Cyclo-oxygenase-2 and its inhibition in cancer: is there a role? Drugs 67: 821–845
  14. 13.Horvath Z, Murias M, Saiko P et al. (2006) Cytotoxic and biochemical effects of 3,3’,4,4’,5,5’-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. Exp Hematol 34: 1377–1384
  15. 14.Murias M, Handler N, Erker T et al. (2004) Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12: 5571–5578
  16. 15.Benitez DA, Pozo-Guisade E, Alvarez-Barrientos A et al. (2007) Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl 28: 282–293
  17. 16.Kampa M, Hatzoglou A, Notas G et al. (2000) Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer 37: 23–33

產品目錄  |  Home  |  主打產品  |  植物提取物  |  天然提取物  |  產品解決方案  |  聯繫我們  |  展會  |  網站地圖  |  手機版
  English     简体版     繁體版
網站首頁聯繫我們網站地圖